Emerald Health Therapeutics
Maheep brings more than 10 years of corporate development experience in catalyzing ground floor projects through corporate administration, finance, M&A, management, investor relations and operations. Prior to Emerald, Maheep managed multi-million-dollar agricultural development projects in BC and has worked closely within Health Canada’s MMPR and ACMPR medical cannabis frameworks since 2014. As a founding member of the Emerald group of companies, Mr. Dhillon was involved in raising over $75 million, managing critical partnerships and coordinating the public launch of Emerald Health Therapeutics (EHT). In 2017, he was appointed VP of Corporate Development for EHT and managed initiatives in operations, strategic partnering, marketing and business development. Mr. Dhillon most recently co-lead the conversion and licensing of EHT’s 1.1 million square foot joint venture hybrid greenhouse facility in Delta, BC. He is currently focused on establishing Agro-Biotech in Quebec, acquiring global cannabis assets, cannabis research, cannabis production and creating intellectual property.